ANCO upcoming events

Harvesting Knowledge: A Summit on Multiple Myeloma (04/24/2026)

Fri, 24 Apr 2026 07:00:00 GMT

Harvesting Knowledge: A Summit on Multiple Myeloma

This clinically focused program is designed to sharpen decision-making across the multiple myeloma continuum. Together with expert faculty and peers, you’ll:

Evaluate up-to-the-minute strategies for smoldering, newly diagnosed, and relapsed/refractory disease

Compare sequencing approaches across therapy classes and diverse patient scenarios

Discuss real-world experience with recently approved agents—including bispecific antibodies—and how these insights can inform care

Assess mitigation tactics for treatment-related adverse events to maintain efficacy while protecting quality of life

Expect interactive cases, practical algorithms, and candid “what I would do tomorrow” discussions that you can immediately apply in your practice.

CLICK HERE to register for this year’s program.

100% off discount code: MMSummit100

We hope you’ll join us in Napa for this important regional gathering. Your participation would help strengthen collaboration and elevate care for patients throughout Northern California.

If you have any questions, please reach out to Shelby.abuhatzira@ucsf.edu

Hematologic Malignancies Update 2026 (05/02/2026)

Sat, 02 May 2026 15:00:00 GMT

Join us for Hematologic Malignancies Update 2026 taking place at the Hyatt Regency Monterey, May 2-3, 2026!

Meeting Overview

Hematologic Malignancies Update 2026 is a two-day meeting provides hematology and oncology clinicians, nurses, nurse practitioners and physician assistants with an overview of the most recent advances in the treatment of various hematologic malignancies.

Invited speakers choose exciting and relevant topics and discuss their clinical relevance to the hematology and oncology practice. Check out the AGENDA by clicking here!

Industry Waitlist is open. Click "Register" above to add yourself to the waitlist. Please read below to understand our Industry Registration Waitlist Policy:

At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited.Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.

Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium (05/07/2026)

Thu, 07 May 2026 15:00:00 GMT

The Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium is a two-day hybrid educational activity designed to address the evolving landscape of hematopoietic cell transplantation (HCT) and cellular therapies. As the number of eligible patients and range of disease indications continue to expand, and as supportive care requirements grow increasingly complex, there is a critical need for ongoing education among healthcare providers who refer, manage, and care for these patients before, during, and after therapy.

This symposium will provide a comprehensive review of state-of-the-art transplant and cellular therapy approaches for hematologic malignancies and select non-hematologic diseases. Faculty experts will highlight advances in treatment strategies, emerging research, and best practices in supportive care, equipping participants with the knowledge and tools to optimize patient outcomes across the continuum of care.

For more information, click HERE.

Healthy Lungs California Advocacy Day (05/18/2026)

Mon, 18 May 2026 16:30:00 GMT

ANCO & MOASC MD Member Luncheon at ASCO (05/31/2026)

Sun, 31 May 2026 16:30:00 GMT

This lunch is for all ANCO and MOASC MD, Fellows, and Prospective MD and Fellow Members who are attending the ASCO Annual Meeting. This meeting is for practitioners only; industry representatives may not attend.

Lunch will be served from 11:30am - 1:30pm at the Hyatt Regency McCormick Place in the Regency CD room. Come by whenever you can!

This is not an official event of the 2026 ASCO Annual Meeting. It is not sponsored, endorsed, or accredited by ASCO or Conquer Cancer®, the ASCO Foundation. Please let us know if you plan to attend by Friday, May 22nd.

ANCO’s ASCO26 Highlights (08/15/2026)

Sat, 15 Aug 2026 17:00:00 GMT

Join us for ANCO’s ASCO26 Highlights taking place at the InterContinental San Francisco on August 15, 2026!

Meeting Overview

ANCO’s ASCO26 Highlights will summarize the major research and treatment advancements presented at this year’s ASCO26 Annual Meeting.

Please note, this meeting is not in affiliation in any way with ASCO.

The program will focus on developmental therapeutics, breast, gastrointestinal, genitourinary, head and neck, gynecologic, lung, hematologic malignancies, sarcoma, as well as, melanoma, and end with a panel discussion.

The faculty will place these developments in context as to their immediate clinical utility.

Registration will open in late spring 2026.

Industry Registration is not open yet. Please read below to understand ANCO's industry registraiton waitlist process:

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.

Northern California Genitourinary Cancer Research Forum (09/19/2026)

Sat, 19 Sep 2026 14:30:00 GMT

Join us for the Northern California Genitourinary Cancer Research Forum taking place at the Claremont Resort & Club, September 19, 2026!

Meeting Overview

Clinical trials are the engine of progress in oncology, offering the most promising potential therapies and, often, the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.

We invite you to join us for an innovative one-day educational meeting that bridges this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer.

Registration

Registration will open in spring 2026.

Industry Registration

What is ANCO’s Industry Registration policy?

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.

Precision Oncology Symposium 2026 (11/07/2026)

Sat, 07 Nov 2026 08:00:00 GMT

Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!

Meeting Overview

Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the relevance of this approach.

However, the landscape of available diagnostic technologies and targeted drugs is rapidly changing, making it extremely difficult for practicing oncologists and related professionals to stay up to date and to offer their patients the best molecular diagnostic approach possible. By attending this meeting, clinicians will be informed on cutting edge technologies and their optimal clinical application.

Registration

Registration will open in spring 2026.

Industry Registration

What is ANCO’s Industry Registration policy?

This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.

How does the ANCO Industry Registration waitlist approval process work?

ANCO meetings have spots for up to 45 industry registrations, outside of exhibitors (only exception is MMC, as we go up to 120 Industry).
Once all exhibitors have confirmed their registrants, ANCO will determine how many industry registration spots are available, and will review the waitlist.
Six weeks prior to the meeting starting, ANCO will begin approving industry registrations from the waitlist, priority will be given to industry representatives who are not exhibiting.
Two weeks prior to ANCO meetings, ANCO will review the remaining waitlisted industry registrations. If additional space is available, ANCO may approve up to three additional industry registrations per company on the waitlist.